Drug Profile
Research programme: EP4 receptor agonists - Merck Canada
Alternative Names: L-902688Latest Information Update: 25 Oct 2018
Price :
$50
*
At a glance
- Originator Merck Frosst
- Class
- Mechanism of Action Prostaglandin E4 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Glaucoma
Most Recent Events
- 27 Sep 2006 Preclinical trials in Glaucoma in Canada (Ophthalmic)